down arrow

Genix Pharmaceuticals Corp.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA37232A1093
CAD
0.03
0.00 (0.00%)

Dec 04

TSX

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Glow LifeTech Corp.
Irwin Naturals, Inc.
Lotus Ventures, Inc.
HYTN Innovations, Inc.
Ayurcann Holdings Corp.
Sweet Earth Holdings Corp.
The BC Bud Corp.
Nova Mentis Life Science Corp.
Genix Pharmaceuticals Corp.
nDatalyze Corp.
Mydecine Innovations Group, Inc.
Why is Genix Pharmaceuticals Corp. ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Is Genix Pharmaceuticals Corp. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Genix Pharmaceuticals Corp.
-54.55%
-0.59
117.19%
S&P/TSX 60
19.1%
1.23
15.27%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
-5.09%
EBIT to Interest (avg)
-0.62
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.53
Sales to Capital Employed (avg)
-0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-1.25
EV to EBIT
-2.50
EV to EBITDA
-2.50
EV to Capital Employed
-2.50
EV to Sales
2.50
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CAD -0.16 MM

RAW MATERIAL COST(Y)

Fallen by -99.8% (YoY

OPERATING PROFIT(Q)

Highest at CAD -0.03 MM

PRE-TAX PROFIT(Q)

Highest at CAD -0.05 MM

NET PROFIT(Q)

Highest at CAD -0.05 MM

-14What is not working for the Company
NET SALES(9M)

At CAD 0 MM has Grown at -97.72%

INTEREST(HY)

At CAD 0.08 MM has Grown at 55.35%

INVENTORY TURNOVER RATIO(HY)

Lowest at 0.76%

DEBTORS TURNOVER RATIO(HY)

Lowest at 0.33%

Here's what is working for Genix Pharmaceuticals Corp.
Operating Cash Flow
Highest at CAD -0.16 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CAD MM)

Operating Profit
Highest at CAD -0.03 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (CAD MM)

Pre-Tax Profit
Highest at CAD -0.05 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CAD MM)

Pre-Tax Profit
At CAD -0.05 MM has Grown at 64.97%
over average net sales of the previous four periods of CAD -0.15 MM
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CAD MM)

Net Profit
Highest at CAD -0.05 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CAD MM)

Net Profit
At CAD -0.05 MM has Grown at 64.97%
over average net sales of the previous four periods of CAD -0.15 MM
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CAD MM)

Raw Material Cost
Fallen by -99.8% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Genix Pharmaceuticals Corp.
Interest
At CAD 0.08 MM has Grown at 55.35%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CAD MM)

Net Sales
At CAD 0 MM has Grown at -97.72%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (CAD MM)

Inventory Turnover Ratio
Lowest at 0.76% and Fallen
In each half year in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio
Lowest at 0.33%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."